SNDL, Inc.

As of October 10, 2025, SNDL, Inc. shows a mildly bullish trend with mixed technical indicators, outperforming the S&P 500 in the short term but significantly underperforming over the past three to five years.

As of October 10, 2025, SNDL, Inc. shows a mildly bullish trend with positive momentum from the MACD and moving averages, but caution is advised due to a bearish monthly RSI.

As of October 10, 2025, SNDL, Inc. has a mildly bullish technical trend, supported by a bullish weekly MACD and daily moving averages, despite bearish signals in the monthly RSI and KST.

As of September 2, 2025, SNDL, Inc. shows a mildly bullish trend with a bullish MACD and Bollinger Bands, despite a bearish weekly RSI and mixed signals from moving averages and KST, while outperforming the S&P 500 recently but underperforming over the long term.

As of March 30, 2020, SNDL, Inc. is considered overvalued and risky due to its negative P/E ratio, poor return metrics, and unfavorable valuation ratios compared to peers, despite a short-term 1-year return of 20.19%.

As of March 30, 2020, SNDL, Inc. is considered overvalued and risky due to its negative P/E ratio, low Price to Book Value of 0.44, and an EV to Sales ratio of 0.29, along with a significant year-to-date decline of 30.73% compared to the S&P 500's gain of 2.44%.

As of June 17, 2025, SNDL, Inc. exhibits a mildly bearish trend due to bearish daily moving averages and Bollinger Bands, despite some mildly bullish signals from the MACD, leading to a cautious outlook overall.

SNDL, Inc. is a cannabis company focused on the production, distribution, and sale of cannabis for medical and adult-use markets. As of March 2025, it reported net sales of $143 million and a net loss of $10 million, with a market cap of $329.34 million.

As of Jun 18, SNDL, Inc. has a market capitalization of 329.34 million and reported net sales of 667.48 million with a net profit of -76.15 million over the latest four quarters.